Cintas Corp (CTAS):企業の財務・戦略的SWOT分析

◆英語タイトル:Cintas Corp (CTAS) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA8010385
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月27日
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single UserUSD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Cintas Corp (CTAS) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Cintas Corporation (Cintas) is a specialized products and services provider that offers corporate identity uniforms, entrance uniforms, promotional products, first aid, restroom and hygiene service, safety and fire protection products. Its product portfolio includes fire alarm monitoring, sprinkler systems, kitchen fire suppression systems, special hazard suppression systems mats, mops, flame resistant clothing and shop towels and other ancillary items. The company operates rental processing plants, rental branches, first aid, safety and fire protection facilities, direct sales offices, manufacturing facilities and distribution facilities. Cintas serves food service, healthcare, automotive, gaming and hospitality industries among others. It operates in the countries across North America, Latin America, Europe and Asia. Cintas is headquartered in Cincinnati, Ohio, the US.

Cintas Corp Key Recent Developments

Dec 22,2017: Cintas reports Q2 fiscal 2018 results
Sep 26,2017: Cintas net revenue surges by 27.2% in Q1 2018
Sep 07,2017: Cintas to close distribution center, lay off staff
Jul 20,2017: Cintas reports lower Q4 net income, provides guidance for fiscal 2018
Jun 20,2017: Cintas expanding adding new jobs in Greenville

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Cintas Corp – Key Facts 5
Cintas Corp – Key Employees 6
Cintas Corp – Key Employee Biographies 7
Cintas Corp – Major Products and Services 8
Cintas Corp – History 10
Cintas Corp – Company Statement 12
Cintas Corp – Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Section 2 – Company Analysis 17
Company Overview 17
Cintas Corp – Business Description 17
Cintas Corp – Corporate Strategy 18
Cintas Corp – SWOT Analysis 19
SWOT Analysis – Overview 19
Cintas Corp – Strengths 19
Cintas Corp – Weaknesses 20
Cintas Corp – Opportunities 21
Cintas Corp – Threats 22
Cintas Corp – Key Competitors 23
Section 3 – Company Financial Ratios 24
Financial Ratios – Capital Market Ratios 24
Financial Ratios – Annual Ratios 25
Performance Chart 28
Financial Performance 28
Financial Ratios – Interim Ratios 29
Financial Ratios – Ratio Charts 30
Cintas Corp, Recent Deals Summary 31
Section 4 – Company’s Recent Developments 32
Jul 20, 2017: Cintas reports lower Q4 net income, provides guidance for fiscal 2018 32
Mar 22, 2017: Cintas Q3 net income increases 33
Dec 23, 2016: Cintas Corporation announces fiscal 2017 Q2 results 34
Sep 27, 2016: Cintas Corporation announces fiscal 2017 first quarter results 35
Aug 03, 2016: Cintas announces the retirement of Chairman Robert J. Kohlhepp 36
Jul 19, 2016: Cintas Corporation announces fiscal 2016 fourth quarter and full year results 37
Mar 22, 2016: Cintas Corporation announces fiscal 2016 third quarter results 38
Section 5 – Appendix 39
Methodology 39
Ratio Definitions 39
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
Cintas Corp, Key Facts 5
Cintas Corp, Key Employees 6
Cintas Corp, Key Employee Biographies 7
Cintas Corp, Major Products and Services 8
Cintas Corp, History 10
Cintas Corp, Other Locations 14
Cintas Corp, Subsidiaries 15
Cintas Corp, Key Competitors 23
Cintas Corp, Ratios based on current share price 24
Cintas Corp, Annual Ratios 25
Cintas Corp, Annual Ratios (Cont...1) 26
Cintas Corp, Annual Ratios (Cont...2) 27
Cintas Corp, Interim Ratios 29
Cintas Corp, Recent Deals Summary 31
Currency Codes 39
Capital Market Ratios 39
Equity Ratios 40
Profitability Ratios 40
Cost Ratios 41
Liquidity Ratios 41
Leverage Ratios 42
Efficiency Ratios 42

★海外企業調査レポート[Cintas Corp (CTAS):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AnaptysBio Inc (ANAB):製薬・医療:M&Aディール及び事業提携情報
    Summary AnaptysBio Inc (AnaptysBio) is a clinical-stage biotechnology company that focuses on the development of antibody product candidates for the treatment of inflammatory, autoimmune and atopic diseases. The company develops its product candidates through its proprietary antibody discovery techn …
  • MADO Ice Cream & Foodstuffs Co., Ltd.:企業の戦略・SWOT・財務分析
    MADO Ice Cream & Foodstuffs Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary MADO Ice Cream & Foodstuffs Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Steel Authority of India Ltd:企業のM&A・事業提携・投資動向
    Steel Authority of India Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Steel Authority of India Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • University of Wollongong:企業の戦略的SWOT分析
    University of Wollongong - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Societe Nationale Industrielle et Miniere:企業の戦略・SWOT・財務情報
    Societe Nationale Industrielle et Miniere - Strategy, SWOT and Corporate Finance Report Summary Societe Nationale Industrielle et Miniere - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • U.S. Department of Veterans Affairs-製薬・医療分野:企業M&A・提携分析
    Summary U.S. Department of Veterans Affairs (DVA) is a healthcare organization that provides benefit management and veteran services. The organization provides general benefits information, disability compensation, pension, GI bill, vocational rehabilitation and employment, vet success, educational …
  • Crossbeta Biosciences BV:製薬・医療:M&Aディール及び事業提携情報
    Summary Crossbeta Biosciences BV (Crossbeta) is a biotech company that offers drug discovery programs for the treatment of misfolded protein diseases. The company develops drugs against Alzheimer’s, Parkinson’s, Huntington’s disease and ALS. It offers screening of oligomer-specific therapeutics and …
  • Inova Health System:医療機器:M&Aディール及び事業提携情報
    Summary Inova Health System (Inova) is a non-profit health care delivery system. It owns owns, operates and manages several research, educational, clinical and hospital facilities. It offers home health and long term care services, joint replacement services, liver disease services, mental health se …
  • GE Power India Ltd:企業の戦略・SWOT・財務情報
    GE Power India Ltd - Strategy, SWOT and Corporate Finance Report Summary GE Power India Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Almac Discovery Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Almac Discovery Ltd (Almac Discovery) a subsidiary of Almac Group Ltd is a healthcare service provider that discovers and develops drugs for the treatment of cancer. The company develops drugs, small molecule and therapeutic peptide, biomarkers and diagnostic tools. It provides early drug di …
  • Chubb European Group SE:企業の戦略的SWOT分析
    Chubb European Group SE - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Asian Citrus Holdings Ltd (73):企業の財務・戦略的SWOT分析
    Asian Citrus Holdings Ltd (73) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • InnoMedica Holding AG-製薬・医療分野:企業M&A・提携分析
    Summary InnoMedica Holding AG (InnoMedica) discovers and develops therapeutics for the treatment of cancer. The company develops drugs using its proprietary drug delivery technology, Talidox, based on the transport and release of active pharmaceutical agents, locally, at the target area. Its pipelin …
  • Aspen Pharmacare Holdings Ltd (APN):製薬・医療:M&Aディール及び事業提携情報
    Summary Aspen Pharmacare Holdings Ltd (Aspen) is a specialty and generic pharmaceuticals company that provides pharmaceutical drugs for a range of acute and chronic conditions. The company focuses on thrombosis, anesthetics and high potency and cytotoxics therapeutic categories. It also manufactures …
  • Skinvisible Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Skinvisible Pharmaceuticals Inc (Skinvisible Pharmaceuticals), a subsidiary of Skinvisible Inc, is a pharmaceutical company that develops and manufactures prescription and over the counter dermatology, medical, cosmetic, consumer goods, and skincare products. The company provides products su …
  • United Networks Ltd (UNL):企業の財務・戦略的SWOT分析
    United Networks Ltd (UNL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Groupe Bruxelles Lambert SA:企業の戦略・SWOT・財務情報
    Groupe Bruxelles Lambert SA - Strategy, SWOT and Corporate Finance Report Summary Groupe Bruxelles Lambert SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Biosense Webster Inc:企業の製品パイプライン分析2018
    Summary Biosense Webster Inc (Biosense Webster), a subsidiary of Johnson & Johnson, is a medical device company that designs, manufactures and markets cardiac arrhythmias products. The company’s products include ablation catheters, diagnostic catheters and access, ultrasound catheters and 3D cardiac …
  • Puget Energy, Inc.:企業の戦略・SWOT・財務情報
    Puget Energy, Inc. - Strategy, SWOT and Corporate Finance Report Summary Puget Energy, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Hebron Technology Co., Ltd. (HEBT):企業の財務・戦略的SWOT分析
    Hebron Technology Co., Ltd. (HEBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆